532 related articles for article (PubMed ID: 10807047)
1. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
Neurath MF
Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer approaches for the treatment of inflammatory bowel disease.
Wirtz S; Neurath MF
Gene Ther; 2003 May; 10(10):854-60. PubMed ID: 12732871
[TBL] [Abstract][Full Text] [Related]
3. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor RB
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
[TBL] [Abstract][Full Text] [Related]
5. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
6. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
Amati L; Caradonna L; Jirillo E; Caccavo D
Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
[TBL] [Abstract][Full Text] [Related]
7. Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP; MacDonald TT
Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
[TBL] [Abstract][Full Text] [Related]
8. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
Dieleman LA; Peña AS; Meuwissen SG; van Rees EP
Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314
[TBL] [Abstract][Full Text] [Related]
9. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
10. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
11. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
Agius LM
J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
Fiocchi C
Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.
Leach MW; Bean AG; Mauze S; Coffman RL; Powrie F
Am J Pathol; 1996 May; 148(5):1503-15. PubMed ID: 8623920
[TBL] [Abstract][Full Text] [Related]
15. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
Dignass AU; Baumgart DC; Sturm A
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
[TBL] [Abstract][Full Text] [Related]
16. Signaling for inflammation and repair in inflammatory bowel disease.
Neuman MG
Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
[TBL] [Abstract][Full Text] [Related]
17. New therapies for inflammatory bowel disease: from the bench to the bedside.
Danese S
Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
[TBL] [Abstract][Full Text] [Related]
18. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
Reuter BK; Pizarro TT
Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
[TBL] [Abstract][Full Text] [Related]
19. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
Madsen JR
Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
[TBL] [Abstract][Full Text] [Related]
20. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
